ah 6809 has been researched along with Invasiveness, Neoplasm in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, L; Feng, D; Liang, H; Liang, J; Ling, B; Yan, K; Zhang, X | 1 |
| Chakrabarti, S; Chakraborty, C; Lala, PK; Timoshenko, AV; Xu, G | 1 |
| Iwamoto, J; Matsuoka, T; Matsuzaki, Y; Mizokami, Y; Takahashi, K | 1 |
3 other study(ies) available for ah 6809 and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Cyclooxygenase 2 Promotes Proliferation and Invasion in Ovarian Cancer Cells via the PGE2/NF-κB Pathway.
Topics: Animals; Antineoplastic Agents; Celecoxib; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Female; Humans; Mice, Nude; Neoplasm Grading; Neoplasm Invasiveness; NF-kappa B; Nitriles; Ovarian Neoplasms; Phosphorylation; Receptors, Prostaglandin E, EP2 Subtype; Signal Transduction; Sulfones; Transplantation, Heterologous; Xanthones | 2019 |
Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
Topics: Alprostadil; Animals; Breast Neoplasms; Carcinoma; Cell Movement; Colforsin; Cyclic AMP; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide; Dinoprostone; Dose-Response Relationship, Drug; Female; Humans; Indoles; Isoenzymes; Mammary Neoplasms, Experimental; Membrane Proteins; Mice; Neoplasm Invasiveness; Prostaglandin-Endoperoxide Synthases; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Tumor Cells, Cultured; Up-Regulation; Xanthenes; Xanthones | 2003 |
The effects of cyclooxygenase2-prostaglandinE2 pathway on Helicobacter pylori-induced urokinase-type plasminogen activator system in the gastric cancer cells.
Topics: Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Helicobacter pylori; Humans; Neoplasm Invasiveness; Receptors, Cell Surface; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Urokinase Plasminogen Activator; RNA, Messenger; Signal Transduction; Stomach Neoplasms; Urokinase-Type Plasminogen Activator; Xanthones | 2008 |